1.A Case of Granulocyte-Colony Stimulating Factor-Producing Hepatocellular Carcinoma Confirmed by Immunohistochemistry.
Satoru JOSHITA ; Koh NAKAZAWA ; Shoichiro KOIKE ; Atsushi KAMIJO ; Kiyoshi MATSUBAYASHI ; Hideharu MIYABAYASHI ; Kiyoshi FURUTA ; Kiyoshi KITANO ; Kaname YOSHIZAWA ; Eiji TANAKA
Journal of Korean Medical Science 2010;25(3):476-480
Granulocyte-colony stimulating factor (G-CSF) is a naturally occurring glycoprotein that stimulates the proliferation and maturation of precursor cells in the bone marrow into fully differentiated neutrophils. Several reports of G-CSF-producing malignant tumors have been published, but scarcely any in the hepatobiliary system, such as in hepatocellular carcinoma (HCC). Here, we encountered a 69-yr-old man with a hepatic tumor who had received right hepatic resection. He showed leukocytosis of 25,450/microL along with elevated serum G-CSF. Histological examination of surgical samples demonstrated immunohistochemical staining for G-CSF, but not for G-CSF receptor. The patient survived without recurrence for four years, but ultimately passed away with multiple bone metastases. In light of the above, clinicians may consider G-CSF-producing HCC when encountering patients with leukocytosis and a hepatic tumor. More cases are needed to clarify the clinical picture of G-CSF-producing HCC.
Aged
;
Bone Neoplasms/secondary
;
Carcinoma, Hepatocellular/*metabolism/pathology
;
Fatal Outcome
;
Granulocyte Colony-Stimulating Factor/*metabolism
;
Humans
;
Liver Neoplasms/*metabolism/pathology
;
Male
;
Receptors, Granulocyte Colony-Stimulating Factor/metabolism
2.Clinical Usefullness of a Database Obtained from the Experience of Physicians Prescribing Herbal Medicines : Report on a Questionnaire Regarding Treatment for Chillness of the Limbs
Norio IIZUKA ; Akihiro UCHIZONO ; Takaaki KITANO ; Yasumasa SATO ; Sadahiro SEMPUKU ; Hajime NAKAE ; Yoshihiro NISHIDA ; Ginryu FUKUMOTO ; Kiyoshi MINAMIZAWA ; Kojiro YAMAGUCHI ; Shinei RYU
Kampo Medicine 2014;65(2):138-147
Aim of the present study was to statistically evaluate the examination rule with use of a questionnaire obtained from physicians regarding treatment for chillness of the limbs, and to prove the clinical usefulness of the database. The database showed that tokishigyakukagoshuyushokyoto was the most frequently used to treat chillness of the limbs, and subsequently keishikajutsubuto, hachimijiogan, and tokishakuyakusan were ranked as drugs with wide use. When physicians determined a kampo formulation suitable for each patient, they used findings specific for the kampo formulation, but not uniform findings obtained from the four traditional examination methods (i.e., inspection, listening and smelling, interviewing, palpitation). There was a statistical difference in the selection mode of drugs among physicians. In a simulation obtained from a questionnaire, there was a positive association between time (time X) to the start of becoming physically warm in the limbs, and time (time Y) to remission (R2 = 0.971, P = 0.014). The formula (Y = 4.379 X−0.519), which could predict time Y on the basis of information on time X, was able to accurately monitor the clinical courses of 7 responders to treatment for chillness of the limbs. Taken together, these results strongly suggest that the database constructed in the present study may be useful for evaluation of traditional Kampo medicine, and might allow us to perform more fittingly personalized Kampo medicine in the near future.